IRIS
DEL POETA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 71.127
EU - Europa 6.403
AS - Asia 6.326
SA - Sud America 983
AF - Africa 94
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 17
Totale 84.969
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 70.953
SG - Singapore 2.911
DE - Germania 1.803
CN - Cina 1.455
UA - Ucraina 1.018
RU - Federazione Russa 934
BR - Brasile 798
IE - Irlanda 635
HK - Hong Kong 616
VN - Vietnam 530
IT - Italia 528
GB - Regno Unito 416
FR - Francia 300
FI - Finlandia 250
SE - Svezia 226
KR - Corea 218
JP - Giappone 182
CA - Canada 93
IN - India 86
NL - Olanda 71
AR - Argentina 52
PL - Polonia 52
BD - Bangladesh 48
MX - Messico 45
ZA - Sudafrica 43
AT - Austria 35
TR - Turchia 35
UZ - Uzbekistan 32
BE - Belgio 27
ES - Italia 27
EC - Ecuador 26
PH - Filippine 26
ID - Indonesia 24
IQ - Iraq 24
CL - Cile 20
SA - Arabia Saudita 20
VE - Venezuela 19
UY - Uruguay 17
CO - Colombia 16
PE - Perù 16
AU - Australia 15
PY - Paraguay 15
CZ - Repubblica Ceca 14
PK - Pakistan 13
TH - Thailandia 13
CH - Svizzera 9
EU - Europa 9
IL - Israele 9
KE - Kenya 9
LT - Lituania 9
EG - Egitto 8
MA - Marocco 8
NP - Nepal 8
A2 - ???statistics.table.value.countryCode.A2??? 7
JO - Giordania 7
KZ - Kazakistan 7
MY - Malesia 7
RO - Romania 7
SN - Senegal 7
AL - Albania 6
DK - Danimarca 6
DM - Dominica 6
DO - Repubblica Dominicana 6
GR - Grecia 6
LB - Libano 6
TN - Tunisia 6
AZ - Azerbaigian 5
DZ - Algeria 5
IR - Iran 5
JM - Giamaica 5
KG - Kirghizistan 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
HN - Honduras 4
HR - Croazia 4
NO - Norvegia 4
OM - Oman 4
PT - Portogallo 4
AO - Angola 3
BH - Bahrain 3
BO - Bolivia 3
BY - Bielorussia 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
NZ - Nuova Zelanda 3
QA - Qatar 3
TW - Taiwan 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BW - Botswana 2
CY - Cipro 2
GD - Grenada 2
GE - Georgia 2
GT - Guatemala 2
KW - Kuwait 2
MN - Mongolia 2
PS - Palestinian Territory 2
BG - Bulgaria 1
BS - Bahamas 1
Totale 84.954
Salva come PNG Salva come JPEG
Città #
Woodbridge 22.016
Wilmington 17.836
Houston 15.523
Fairfield 2.049
Ann Arbor 1.727
Singapore 1.655
Ashburn 1.319
Chandler 1.132
Jacksonville 920
Seattle 845
San Jose 779
Cambridge 711
Dublin 623
Hong Kong 602
Beijing 569
Dearborn 519
Medford 465
Santa Clara 296
New York 289
The Dalles 280
Dallas 239
Lawrence 219
Ho Chi Minh City 180
Los Angeles 175
Zhengzhou 173
Tokyo 143
Moscow 140
Lauterbourg 133
Buffalo 130
Hanoi 127
Rome 120
Mülheim 106
San Diego 104
Munich 76
São Paulo 76
Council Bluffs 70
Menlo Park 62
Milan 61
Chicago 53
University Park 49
London 48
Hefei 46
Boardman 42
Nanjing 42
Mountain View 41
Norwalk 40
Redondo Beach 39
Brooklyn 38
Shanghai 38
Warsaw 38
Orem 37
Montreal 36
Nuremberg 36
Helsinki 34
Creede 32
Frankfurt am Main 32
Falls Church 29
Toronto 29
Johannesburg 28
Palo Alto 28
Phoenix 28
Verona 27
Kunming 26
Redwood City 26
Guangzhou 25
Brussels 23
Denver 23
Chennai 22
San Francisco 22
Columbus 21
Rio de Janeiro 21
Haiphong 20
Da Nang 19
Detroit 19
Atlanta 18
Belo Horizonte 18
Poplar 17
Saint Petersburg 17
Amsterdam 16
Boston 16
Mexico City 16
Manchester 15
Montevideo 15
Nürnberg 15
Wuhan 15
Brasília 14
Lima 14
Stockholm 14
Ankara 13
North Bergen 13
Seoul 13
Turku 13
Brno 12
Chengdu 12
Hangzhou 12
Biên Hòa 11
Bologna 11
Hải Dương 11
Jakarta 11
Vienna 11
Totale 74.009
Salva come PNG Salva come JPEG
Nome #
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia 627
Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods 542
Femoral catheters: safety and efficacy in peripheral blood stem cell collection 540
A microgranular variant of acute promyelocytic leukemia with atypical morpho-cytochemical features and an early myeloid immunophenotype 532
CD7 expression in acute myeloid leukemia 529
Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods 516
A case of SRSF2 mutation in chronic lymphocytic leukemia 516
AML-M0: A review of laboratory features and proposal of new diagnostic criteria 512
A novel t(11;12)(q23-24;q24) in a case of minimally-differentiated acute myeloid leukemia (AML-M0) 507
Collection of peripheral progenitor cells: a comparison between Amicus and Cobe-Spectra blood cell separators 506
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord blood and G-CSF mobilized peripheral blood 497
Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian multicenter study 496
Minimally differentiated acute myeloid leukemia (AML-MO): a distinct clinico-biologic entity with poor prognosis 496
All-trans-retinoic acid plus low-doses of cytarabine for the treatment of poor-risk acute myeloid leukemias 495
A phase-II trial of all trans retinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromes 494
Graft failure due to hemolytic uremic syndrome recurrence 493
Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors 489
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 489
High expression levels of vla-4 (CD49d) on mobilised peripheral blood stem cells are associated with rapid engraftment in multiple myeloma patients receiving autologous transplant 486
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments 486
Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML) 482
Clinical significance of CD38 expression in chronic lymphocytic leukemia 476
Comparison between conventional banding analysis and FISH screening with an AML specific set of probes in 260 patients 474
Acute lymphoblastic leukemia subsequent to autoimmune hemolytic anemia: a case report 473
The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia. 470
Biological profile of 23 cases of minimally differentiated acute myeloid leukemia (AML-MO) and its clinical implications 470
Multiparametric analysis for the enumeration of CD34+ cells from bone marrow and stimulated peripheral blood 470
Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia. 469
Leukocyte alkaline-phosphatase score in plasma-cell dyscrasias - correlation with disease severity and circulating levels of granulocyte-colony-stimulating factor 468
Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia - Analysis of prognostic factors 467
Diagnosis of acute myeloid leukemia and system Coulter VCS 466
Femoral catheters: safety and efficacy in peripheral blood stem cell collection 464
Central Nervous System Involvement in Adult Acute Lymphoblastic Leukemia: Diagnostic Tools, Prophylaxis, and Therapy. 463
All-trans retinoic acid (ATRA) administration during pregnancy in relapsed acute promyelocytic leukemia 462
Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia 461
Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): Identification of markers with prognostic relevance 460
P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia 460
Minimally differentiated acute myeloid leukemia (AML-MO): Comparison of 25 cases with other French-American-British subtypes 460
Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia 460
Biological features of acute myeloid leukemia in the elderly 460
Clinical relevance of minimal residual disease detection in adult acute myeloid leukemia 459
Bone marrow necrosis as a terminal complication of a very long-lasting polycythemia vera 458
Efficacy and safety of human leucocyte interferon-alpha treatment in patients younger than 60 years of age with polycythaemia vera 457
Analysis of regulatory T cell changes in patients with idiopathic thrombocytopenic purpura receiving B-cell depleting therapy with rituximab 455
Response to B-cell-depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura 454
Soluble factors levels in the initial staging of high-grade non-Hodgkin's lymphomas 454
Clinical implications of cytokine and soluble receptor measurements in patients with newly-diagnosed aggressive non-Hodgkin's lymphoma 453
In vitro infection of leukemic bone marrow with HTLV-I generates immortalized cell lines expressing T or myeloid cell phenotype 449
P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia 448
Activation-induced cytidine deaminase and CD38 expression in B-cell chronic lymphocytic leukemia 446
Lecam1/Icam1 ratio identifies a distinct pattern on normal and myelodysplastic bone marrow CD34+ progenitors cells 445
AML-M0: a biological and clinical profile 445
Chronic lymphocytic leukemia-associated immune thrombocytopenia treated with rituximab: a retrospective study of 21 patients 443
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia. 443
Monocytes/macrophages but not T lymphocytes are the major targets of the CCL3/CCL4 chemokines produced by CD38(+)CD49d(+) chronic lymphocytic leukaemia cells 441
CD7 Expression in acute myeloid leukemia 441
Biological pattern of AML-M0 versus AML-M1: Response 440
Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab 439
Graft failure due to hemolytic uremic syndrome recurrence 439
Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation: results in 378 adult patients 439
Complete regression of cutaneous lesions of refractory Ph+ ALL after 4 weeks of treatment with BMS-354825 438
Pure erythroid leukemia in advanced breast cancer. 438
Molecular characterization of Ph' + hybrid acute leukemia 438
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia 438
A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia 437
Management of hematological malignancies in patients affected by renal failure 436
The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience 436
Hodgkin disease subsequent to follicular lymphoma on maintenance rituximab 436
Gelatinous degeneration of the bone marrow: two case reports showing different hematological features and clinical outcomes 436
FISH analysis for CML monitoring? 436
Cutaneous involvement in multiple myeloma and bortezomib 435
Clinical implication of cytokine and soluble receptor measurements in patients with newly diagnosed aggressive non Hodgkin Lymphomas 434
NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: Evidence for a NOTCH1 mutation-driven epigenetic dysregulation 434
Multidimensional flow cytometry for detection of minimal residual disease in acute myeloid leukemia 432
Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia 430
Minimally differentiated acute myeloid-leukemia (aml-mo): cytochemical, immunophenotypic and cytogenetic analysis of 19 cases 430
Mitoxantrone in combination with etoposide and cytarabine for treatment of poor prognosis acute non lymphoid leukemia patients 428
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia 427
How would I manage a sample submitted for flow cytometry analysis for suspicious chronic lymphocytic leukaemia 426
Discriminant function analysis as decision support system for the diagnosis of acute leukemia with a minimal four color screening panel and multiparameter flow cytometry immunophenotyping 426
Contribution of immunophenotypic and genotypic analysis to the diagnosis of acute leukemia 425
Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0) 425
Red blood cell depletion and cryopreservation of umbilical cord blood (UCB) 423
IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia. 423
All-trans retinoic acid and low dose cytosine arabinoside for the treatment of "poor prognosis" acute myeloid leukemia 421
Cytogenetic and molecular diagnostic characterization combined to post-consolidation minimal residual disease assessment by flow-cytometry improves risk stratification in adult acute myeloid leukemia 419
ZAP-70 expression in B-cell chronic lymphocytic leukemia: evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgV(H) mutations 419
A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia 419
Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia. 418
Fluorescence in situ hybridization and conventional cytogenetics for the diagnosis of 11q23(+)/MLL+ translocation in leukaemia 418
Clinical heterogeneity of idiopathic CD4+T lymphocytopenia 418
Potential therapeutic role of antagomiR17 for the treatment of chronic lymphocytic leukemia. 418
CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival 417
High interleukin-6 plasma levels in acute promyelocytic leukemia 417
Dismal Outcome of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia after Azacitidine Failure in a Daily-Life Setting. 417
Minimally differentiated acute myeloid leukemia (AML-MO): A distinct clinico-biologic entity with poor prognosis 416
Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation 416
Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery 416
P-glycoprotein expression in de novo acute myeloid leukemia 416
In vitro down-regulation of bcl-2 expression by all-trans retinoic acid in AML blasts 415
Totale 45.578
Salva come PNG Salva come JPEG
Categoria #
all - tutte 181.485
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 181.485
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021566 0 0 0 0 0 0 0 0 0 0 465 101
2021/20222.169 71 282 61 107 39 206 119 112 115 222 138 697
2022/20232.879 362 240 206 281 194 631 269 165 286 10 182 53
2023/2024875 101 35 39 15 101 297 44 29 19 11 14 170
2024/20254.519 152 1.210 582 250 61 187 400 207 411 349 314 396
2025/20267.068 680 350 1.094 630 605 305 862 944 892 692 14 0
Totale 85.387